StockData
LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc. (LFST) stock

LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30143% above fair value
$14.15−0.22 (-1.53%)

Close on Nov 12, 2026Market cap $5.41BP/E 74.5Yield –

LifeStance Health operating margin

Operating margin is operating income as a percentage of revenue.

LifeStance Health's operating margin for the twelve months ending Sep 30, 2026 was 6.2%. For fiscal 2025 it was 1.7%, against -2.5% the year before. The highest annual figure on record is 7.2% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20251.7%+4.2
FY2024Dec 31, 2024-2.5%+15.4
FY2023Dec 31, 2023-17.9%+6.5
FY2022Dec 31, 2022-24.5%+18.4
FY2021Dec 31, 2021-42.9%−50.1
FY2019Dec 31, 20197.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 20267.3%+5.2
Q2 FY2026Jun 30, 20267.0%+7.9
Q1 FY2026Mar 31, 20265.5%+5.0
Q4 FY2025Dec 31, 20254.7%+4.4
Q3 FY2025Sep 30, 20252.0%+2.0
Q2 FY2025Jun 30, 2025-0.9%+4.3
Q1 FY2025Mar 31, 20250.5%+6.1
Q4 FY2024Dec 31, 20240.3%+11.8
Q3 FY2024Sep 30, 20240.0%+28.3
Q2 FY2024Jun 30, 2024-5.1%+13.5
Q1 FY2024Mar 31, 2024-5.6%+7.9
Q4 FY2023Dec 31, 2023-11.5%+8.6
Q3 FY2023Sep 30, 2023-28.3%−10.4
Q2 FY2023Jun 30, 2023-18.7%+10.2
Q1 FY2023Mar 31, 2023-13.5%+18.4
Q4 FY2022Dec 31, 2022-20.1%+39.8
Q3 FY2022Sep 30, 2022-17.9%+53.9
Q2 FY2022Jun 30, 2022-28.9%+0.4
Q1 FY2022Mar 31, 2022-31.9%−31.3
Q4 FY2021Dec 31, 2021-59.9%−62.5
Q3 FY2021Sep 30, 2021-71.7%−71.9
Q2 FY2021Jun 30, 2021-29.3%–
Q1 FY2021Mar 31, 2021-0.6%–
Q3 FY2020Sep 30, 20202.6%–
Q2 FY2020Jun 30, 20200.2%–

More LifeStance Health figures

See a number that looks wrong?